Market Overview

Rodman & Renshaw Downgrades Abiomed From MKT Perform To MKT Underperform

Rodman & Renshaw is downgrading shares of Abiomed, Inc. (NASDAQ: ABMD) from Market Perform to Market Underperform.

Posted-In: Abiomed Rodman & RenshawAnalyst Ratings

 

Related Articles (ABMD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters